Back to mobile site

SVB Leerink Downgrades Sio Gene Therapies (SIOX) to Market Perform

February 1, 2022 6:08 AM EST Send to a Friend
SVB Leerink analyst Mani Foroohar downgraded Sio Gene Therapies (NASDAQ: SIOX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login